The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index; none of the 6 sources its claims cite is checked for support yet.
SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin
Open accessAbstract
The Sir2 deacetylase regulates chromatin silencing and lifespan in Saccharomyces cerevisiae. In mice, deficiency for the Sir2 family member SIRT6 leads to a shortened lifespan and a premature ageing-like phenotype. However, the molecular mechanisms of SIRT6 function are unclear. SIRT6 is a chromatin-associated protein, but no enzymatic activity of SIRT6 at chromatin has yet been detected, and the identity of physiological SIRT6 substrates is unknown. Here we show that the human SIRT6 protein is an NAD+-dependent, histone H3 lysine 9 (H3K9) deacetylase that modulates telomeric chromatin. SIRT6 associates specifically with telomeres, and SIRT6 depletion leads to telomere dysfunction with end-to-end chromosomal fusions and premature cellular senescence. Moreover, SIRT6-depleted cells exhibit abnormal telomere structures that resemble defects observed in Werner syndrome, a premature ageing disorder. At telomeric chromatin, SIRT6 deacetylates H3K9 and is required for the stable association of WRN, the factor that is mutated in Werner syndrome. We propose that SIRT6 contributes to the propagation of a specialized chromatin state at mammalian telomeres, which in turn is required for proper telomere metabolism and function. Our findings constitute the first identification of a physiological enzymatic activity of SIRT6, and link chromatin regulation by SIRT6 to telomere maintenance and a human premature ageing syndrome.
Overview
AI snapshot
Written from the paper’s full text.
TL;DR
Human SIRT6 is an NAD+-dependent histone H3 lysine 9 (H3K9) deacetylase that associates with telomeres in S phase and maintains low H3K9 acetylation there. SIRT6 depletion causes telomere dysfunction, chromosomal end-to-end fusions, and premature cellular senescence, and impairs WRN association at telomeric chromatin, linking SIRT6 to telomere maintenance and Werner syndrome-like defects.
Key findings
- SIRT6 knockdown in WI-38 human fibroblasts shortened replicative lifespan, causing premature senescence about ten population doublings before controls, with increased senescence-associated β-galactosidase staining; two independent SIRT6 shRNAs reproduced this, while irrelevant shRNAs did not.
- SIRT6-depleted cells showed elevated telomere dysfunction-induced foci, non-recurrent chromosomal end-to-end fusions that were more pronounced at later population doublings, and Werner syndrome-like telomere abnormalities including sister telomere loss, telomere doublets, and weak or absent telomere signals at fusion sites; mean telomere length was not significantly reduced.
- SIRT6 deacetylated H3K9Ac specifically among tested acetylated histone peptides, with no deacetylation detected for 12 other acetylated histone peptides; the catalytic mutant H133Y markedly decreased activity. SIRT6 knockdown caused H3K9 hyperacetylation at telomeric chromatin in S phase, and S6KO mouse cells also showed telomeric H3K9 hyperacetylation.
- SIRT6 was required for stable WRN association at telomeric chromatin; SIRT6 knockdown significantly inhibited WRN association in U2OS and IMR90 cells. Telomerase expression reversed premature senescence, whereas augmenting base excision repair did not, and low oxygen culture did not prevent senescence.
Methods
- Retrovirus-mediated shRNA knockdown of SIRT6 in WI-38, IMR90, U2OS, and HeLa cells, with replicative senescence assays, SA-β-gal staining, immuno-FISH TIF assays, metaphase cytogenetics/SKY/telomere FISH, and cell-cycle flow cytometry.
- Telomere chromatin immunoprecipitation (T-ChIP) after thymidine synchronization and release, using antibodies against SIRT6, Flag, WRN, and H3K9Ac, with telomeric DNA detected by slot blot.
- In vitro histone deacetylation assays with recombinant SIRT6 and acetylated histone tail peptides or full-length histones, including mass spectrometry; 293T cells were transfected with wild-type or H133Y SIRT6 and analyzed by Western blotting.
Limitations
- Stated: SIRT6 showed only modest in vitro deacetylation activity on H3K9Ac peptides, and no direct SIRT6-WRN interaction at chromatin was observed, although additional functional or physical interactions might exist.
- Stated: S6KO mouse cells showed telomeric H3K9 hyperacetylation but did not display the downstream cellular defects seen in human cells, which the authors attribute to the large functional reserve of mouse telomeres.
- Evident: many conclusions rely on shRNA knockdown and overexpression in cultured cells, and several supporting results are reported as “data not shown”; global H3K9Ac levels did not differ significantly, so the key effect is telomere-specific.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
29 Own result · 23 Own interpretation · 3 Not checked yet · 1 Own method · 1 No basis given
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“As controls, the association of Alu repeat sequences with SIRT6 ChIPs was not above background (Fig. 2b–d), and the SIRT6 T-ChIP signal was abolished in S6KD cells, validating the specificity of the signal (Fig. 2d).”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In both U2OS and IMR90 cells, SIRT6 knockdown significantly inhibited the association of WRN with telomeric chromatin (Fig. 4a, b, and data not shown).”
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“However, mean telomere length was not significantly reduced in S6KD cells (Supplementary Fig. 5).”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Inactivation of SIRT6 leads to H3K9 hyperacetylation at telomeric chromatin in both human and mouse cells, but the mouse cells do not display the downstream cellular defects observed in human cells, which is consistent with the large functional reserve of mouse telomeres (Supplementary Fig. 13d; data not shown)14,25.”
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“First, telomere stabilization (by the ectopic expression of telomerase (hTERT)) reversed the premature senescence of S6KD, whereas augmenting BER (by the ectopic expression of the DNA polymerase-β dRP lyase domain) did not (Fig. 1g and Supplementary Fig. 6).”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Inactivation of SIRT6 leads to H3K9 hyperacetylation at telomeric chromatin in both human and mouse cells, but the mouse cells do not display the downstream cellular defects observed in human cells, which is consistent with the large functional reserve of mouse telomeres (Supplementary Fig. 13d; data not shown)14,25.”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“First, telomere stabilization (by the ectopic expression of telomerase (hTERT)) reversed the premature senescence of S6KD, whereas augmenting BER (by the ectopic expression of the DNA polymerase-β dRP lyase domain) did not (Fig. 1g and Supplementary Fig. 6).”
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Analysis of TIFs revealed elevated telomere dysfunction in S6KD cells (Fig. 1d, e, and Supplementary Fig. 4a).”
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Similarly, SIRT6 knockdown in U2OS cells resulted in delayed completion of S phase (Supplementary Fig. 14), which is consistent with a role for SIRT6 in modulating telomeres during replication.”
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In contrast, investigation of histone acetylation status at telomeres in S-phase-enriched cultures by T-ChIP revealed H3K9 hyperacetylation in S6KD cells (Fig. 3d–f).”
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- It may state two separate claims as one. 18
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Premature cellular senescence was also observed with two independent SIRT6 shRNAs, ruling out off-target shRNA effects, but not with irrelevant shRNAs (Supplementary Fig 2b–d and Supplementary Fig 3c).”
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“SIRT6 occupancy at telomeric chromatin was observed for both recombinant Flag-tagged SIRT6 (Fig. 2a, b) and endogenous SIRT6 (Fig. 2c, d), and in both U2OS osteosarcoma cells (Fig. 2b, c) and primary IMR90 cells (Fig. 2d).”
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“This activity was highly specific for H3K9Ac, because no deacetylation was detected for 12 other acetylated histone peptides (Fig. 3a and Supplementary Fig. 11).”
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“SIRT6 also deacetylated H3K9Ac, but not several other acetylated residues, in the context of purified full-length histone H3, and mutation of a conserved catalytic residue (H133Y) of SIRT6 markedly decreased this activity (Fig. 3b and data not shown).”
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“SIRT6 knockdown (S6KD) cells have a strikingly shortened replicative lifespan, undergoing premature cellular senescence about ten population doublings before control cells, and show increased levels of senescence-associated β-galactosidase (SA-β-gal) staining (Fig. 1b, c, and Supplementary Fig. 2a).”
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Finally, SIRT6 efficiently and specifically deacetylated H3K9Ac (but not other acetylated histone residues) in 293T cells, whereas the mutant SIRT6 protein did not (Fig. 3c and Supplementary Fig. 12).”
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Non-recurrent chromosomal end-to-end fusions were observed in S6KD cells and were more pronounced at later population doublings, but they were rarely observed in control cells (Fig. 1f and Supplementary Fig. 4b, c).”
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“First, S6KD metaphases showed elevated levels of missing telomere signals (sister telomere loss) and extra telomere signals (telomere doublets) (Fig. 4d–f), defects observed in WS cells and associated with aberrant telomere processing during replication8,13,20.”
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Together, these observations suggest that S6KD cells undergo accelerated senescence and telomere dysfunction in response to stochastic telomere sequence loss, without increased global telomere erosion.”
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We conclude that SIRT6 is crucial in maintaining a normal replicative life-span and in preventing the premature senescence of human cells.”
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Together, these data locate SIRT6 at telomeric chromatin in S phase and suggest a potential role for SIRT6 in regulating replication-associated dynamics in telomere structure.”
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Together, these findings suggest that SIRT6 collaborates with WRN at telomeric chromatin to ensure efficient telomere replication and to prevent the accrual of structural abnormalities at telomeres.”
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Our study has identified a crucial function for SIRT6 in chromatin regulation at mammalian telomeres and provides a new mechanism by which the regulation of chromatin is linked to telomere function, cellular senescence and, potentially, organismal ageing.”
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Together, these observations indicate that SIRT6 is an NAD-dependent deacetylase with specificity for H3K9Ac.”
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We propose a model (Supplementary Fig. 1) in which the deacetylation of H3K9Ac by SIRT6 promotes the formation of a specialized telomeric chromatin state that is required for the stable association of S-phase-dependent telomere-processing factors such as WRN, to prevent aberrant sequence loss or metabolism of telomeres.”
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Together, these findings demonstrate that telomere dysfunction, not BER defects or oxidative stress, underlie the premature senescence phenotype of S6KD cells.”
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We propose that SIRT6 contributes to the propagation of a specialized chromatin state at mammalian telomeres, which in turn is required for proper telomere metabolism and function.”
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Our findings constitute the first identification of a physiological enzymatic activity of SIRT6, and link chromatin regulation by SIRT6 to telomere maintenance and a human premature ageing syndrome.”
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper relies on this without support.
No enzymatic activity of SIRT6 at chromatin has yet been detected, and the identity of physiological SIRT6 substrates is unknown.
“SIRT6 is a chromatin-associated protein3, but no enzymatic activity of SIRT6 at chromatin has yet been detected, and the identity of physiological SIRT6 substrates is unknown.”
“Although no physiological enzymatic activity for SIRT6 on histones or other trans substrate has yet been observed, we proposed that SIRT6 might regulate chromatin at telomeres by deacetylating a specific histone tail residue.”
The paper relies on this without support.
No effect of SIRT6 deficiency on cellular lifespan has been reported.
“Despite the ageing-like phenotype of SIRT6-deficient mice, no effect of SIRT6 deficiency on cellular lifespan has been reported.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“SIRT6 promotes DNA double strand break repair19,20, regulates telomere stability21, suppresses inflammation22 and opposes tumorigenesis23,24.”
From SIRT6 represses LINE1 retrotransposons by ribosylating KAP1 but this repression fails with stress and age (2014) · cites this paper as [21]
In the citing paper
“In human cells, loss of SIRT6, an H3K9 deacetylase that silences telomeres, causes telomere dysfunction and premature cellular senescence (Michishita et al., 2008).”
From The Aging Epigenome (2016) · cites this paper as Michishita et al., 2008
Citations
Cites
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase
Imai, S.-I., Armstrong, C. M., Kaeberlein, M., & Guarente, L. (2000) · Nature · doi:10.1038/35001622 · Cited by 3,510
A DNA damage checkpoint response in telomere-initiated senescence
Fagagna, F. D. D., Reaper, P. M., Clay-Farrace, L., Fiegler, H., Carr, P., von Zglinicki, T., Saretzki, G., Carter, N. P., & Jackson, S. P. (2003) · Nature · doi:10.1038/nature02118 · Cited by 2,917
Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors
Campisi, J. (2005) · Cell · doi:10.1016/j.cell.2005.02.003 · Cited by 2,379
Multicolor Spectral Karyotyping of Human Chromosomes
Schröck, E., du Manoir, S., Veldman, T., Schoell, B., Wienberg, J., Ferguson-Smith, M. A., Ning, Y., Ledbetter, D. H., Bar‐Am, I., Soenksen, D. G., et al. (1996) · Science · doi:10.1126/science.273.5274.494 · Cited by 1,753
Self-citationTRF2 Protects Human Telomeres from End-to-End Fusions
van Steensel, B., Smogorzewska, A., & de Lange, T. (1998) · Cell · doi:10.1016/s0092-8674(00)80932-0 · Cited by 1,709
Genomic Instability and Aging-like Phenotype in the Absence of Mammalian SIRT6
Mostoslavsky, R., Chua, K. F., Lombard, D. B., Pang, W. W., Fischer, M. R., Gellon, L., Liu, P., Mostoslavsky, G., Franco, S., Murphy, M. M., et al. (2006) · Cell · doi:10.1016/j.cell.2005.11.044 · Cited by 1,637
Self-citationDNA Damage Foci at Dysfunctional Telomeres
Takai, H., Smogorzewska, A., & de Lange, T. (2003) · Current Biology · doi:10.1016/s0960-9822(03)00542-6 · Cited by 1,409
Michishita, E., Park, J. Y., Burneskis, J. M., Barrett, J. C., & Horikawa, I. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e05-01-0033 · Cited by 1,364
Self-citationHerbig, U., Jobling, W. A., Chen, B. P. C., Chen, D. J., & Sedivy, J. M. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00256-4 · Cited by 1,344
Cited by
Sorted by citations
Items 401–500 of 998
SIRT6 deacetylase transcriptionally regulates glucose metabolism in heart
Khan, D., Sarikhani, M., Dasgupta, S., Maniyadath, B., Pandit, A. S., Mishra, S., Ahamed, F., Dubey, A., Fathma, N., Atreya, H. S., et al. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26434 · Cited by 60
Sirtuins and Immuno-Metabolism of Sepsis
Wang, X., Buechler, N. L., Woodruff, A. G., Long, D. L., Zabalawi, M., Yoza, B. K., McCall, C. E., & Vachharajani, V. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092738 · Cited by 59
Repairing split ends: SIRT6, mono-ADP ribosylation and DNA repair
Van Meter, M., Mao, Z., Gorbunova, V., & Seluanov, A. (2011) · Aging · doi:10.18632/aging.100389 · Cited by 80
After the grape rush: Sirtuins as epigenetic drug targets in neurodegenerative disorders
Huber, K., & Superti‐Furga, G. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.01.018 · Cited by 60
Multivalent interactions drive nucleosome binding and efficient chromatin deacetylation by SIRT6
Liu, W. H., Zheng, J., Feldman, J. L., Klein, M. A., Kuznetsov, V. I., Peterson, C. L., Griffin, P. R., & Denu, J. M. (2020) · Nature Communications · doi:10.1038/s41467-020-19018-y · Cited by 52
SIRT6 Widely Regulates Aging, Immunity, and Cancer
Li, Y., Jin, J., & Wang, Y. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.861334 · Cited by 61
SIRT6 protects against palmitate-induced pancreatic β-cell dysfunction and apoptosis
Xiong, X., Sun, X., Wang, Q., Qian, X., Zhang, Y., Pan, X., & Dong, X. C. (2016) · Journal of Endocrinology · doi:10.1530/joe-16-0317 · Cited by 59
Structural Basis of Sirtuin 6-Catalyzed Nucleosome Deacetylation
Wang, Z. A., Markert, J. W., Whedon, S. D., Abeywardana, M. Y., Lee, K., Jiang, H., Suarez, C., Lin, H., Farnung, L., & Cole, P. A. (2023) · Journal of the American Chemical Society · doi:10.1021/jacs.2c13512 · Cited by 56
Sirt6 depletion causes spindle defects and chromosome misalignment during meiosis of mouse oocyte
Han, L., Ge, J., Zhang, L., Ma, R., Hou, X., Li, B., Moley, K. H., & Wang, Q. (2015) · Scientific Reports · doi:10.1038/srep15366 · Cited by 57
Zhong, X., Zhang, H., Zhao, Y. J., Sun, Q., Hu, Y., Peng, H., & Zhou, D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066807 · Cited by 62
Kim, E., & Juhnn, Y. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.633198 · Cited by 58
Tilman, G., Loriot, A. E., Beneden, A. V., Arnoult, N., Londoño‐Vallejo, A., Smet, C. D., & Decottignies, A. (2009) · Oncogene · doi:10.1038/onc.2009.23 · Cited by 62
Function of Sirtuins in Biological Tissues
Shoba, B., Lwin, Z. M., Ling, L. S., Bay, B., Yip, G. W. C., & Srinivasan, D. K. (2009) · The Anatomical Record · doi:10.1002/ar.20875 · Cited by 58
Synthesizing and Salvaging NAD+: Lessons Learned from Chlamydomonas reinhardtii
Lin, H., Kwan, A. L., & Dutcher, S. K. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1001105 · Cited by 57
Epigenomics and the Regulation of Aging
Boyd-Kirkup, J. D., Green, C. D., Wu, G., Wang, D., & Han, J. J. (2013) · Epigenomics · doi:10.2217/epi.13.5 · Cited by 57
NAD+ Metabolism in Aging and Cancer
Demarest, T. G., Babbar, M., Okur, M. N., Dan, X., Croteau, D. L., Fakouri, N. B., Mattson, M. P., & Bohr, V. A. (2018) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030518-055905 · Cited by 58
Self-citationSirtuin Modulators: Past, Present, and Future Perspectives
Fiorentino, F., Mautone, N., Menna, M., D’Acunzo, F., Mai, A., & Rotili, D. (2022) · Future Medicinal Chemistry · doi:10.4155/fmc-2022-0031 · Cited by 57
Crosstalk between Sirtuins and Nrf2: SIRT1 activators as emerging treatment for diabetic neuropathy
Patel, S., Khan, H., & Majumdar, A. S. (2022) · Metabolic Brain Disease · doi:10.1007/s11011-022-00956-z · Cited by 59
Chromatin modifications: The driving force of senescence and aging?
DiMauro, T., & David, G. (2009) · Aging · doi:10.18632/aging.100023 · Cited by 58
Liao, C., & Kennedy, B. K. (2014) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/b978-0-12-397920-9.00003-2 · Cited by 59
Regulating Chromatin by Histone Acetylation
Steunou, A., Rossetto, D., & Côté, J. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8624-4_4 · Cited by 58
Explorative Study on Isoform-Selective Histone Deacetylase Inhibitors
Suzuki, T. (2009) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.57.897 · Cited by 57
Characterization of Nuclear Sirtuins: Molecular Mechanisms and Physiological Relevance
Toiber, D., Sebastián, C., & Mostoslavsky, R. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-21631-2_9 · Cited by 57
Sirtuins in dermatology: applications for future research and therapeutics
Serravallo, M., Jagdeo, J. R., Glick, S. A., Siegel, D. M., & Brody, N. (2013) · Archives of Dermatological Research · doi:10.1007/s00403-013-1320-2 · Cited by 57
Studying SIRT6 regulation using H3K56 based substrate and small molecules
Kokkonen, P., Rahnasto‐Rilla, M., Mellini, P., Jarho, E. M., Lahtela-Kakkonen, M. K., & Kokkola, T. (2014) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2014.06.015 · Cited by 56
Mitochondrial sirtuins and metabolic homeostasis
Pirinen, E., Sasso, G. L., & Auwerx, J. H. (2012) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2012.05.001 · Cited by 57
Miteva, Y., & Cristea, I. M. (2013) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m113.032847 · Cited by 58
Deacetylation of XBP1s by sirtuin 6 confers resistance to ER stress-induced hepatic steatosis
Bang, I. H., Kwon, O. K., Hao, L., Park, D., Chung, M.-J., Oh, B., Lee, S., Bae, E. J., & Park, B. (2019) · Experimental & Molecular Medicine · doi:10.1038/s12276-019-0309-0 · Cited by 59
Zhou, H., Zeng, H., Yuan, D., Ren, J., Cheng, S., Yu, H., Ren, F., Wang, Q., Qin, Y.-P., Huang, A., et al. (2019) · Cell Communication and Signaling · doi:10.1186/s12964-019-0491-7 · Cited by 56
Sirt6 regulates lifespan in Drosophila melanogaster
Taylor, J. R., Wood, J. G., Mizerak, E., Hinthorn, S. J., Liu, J., Finn, M., Gordon, S., Zingas, L., Chang, C.-Y., Klein, M. A., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2111176119 · Cited by 56
Mutation of OsNaPRT1 in the NAD Salvage Pathway Leads to Withered Leaf Tips in Rice
Wu, L., Ren, D., Hu, S., Li, G., Dong, G., Jiang, L., Hu, X., Ye, W., Cui, Y., Zhu, L., et al. (2016) · PLANT PHYSIOLOGY · doi:10.1104/pp.15.01898 · Cited by 55
Zhou, Y., Yu, W., Huang, R., Ye, M., & Min, Z. (2019) · Cancer Cell International · doi:10.1186/s12935-019-0730-4 · Cited by 55
Wang, T., Sun, C., Hu, L., Gao, E., Li, C., Wang, H., & Sun, D. (2019) · Biochemistry and Cell Biology · doi:10.1139/bcb-2019-0057 · Cited by 54
Genome-wide analysis of functional sirtuin chromatin targets in yeast
Li, M., Valsakumar, V., Poorey, K., Bekiranov, S., & Smith, J. S. (2013) · Genome biology · doi:10.1186/gb-2013-14-5-r48 · Cited by 54
Trichostatin A inhibits deacetylation of histone H3 and p53 by SIRT6
Wood, M., Rymarchyk, S., Zheng, S. G., & Cen, Y. (2017) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2017.12.009 · Cited by 59
Suganuma, T., & Workman, J. L. (2018) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-062917-012634 · Cited by 55
Shang, J., Zhu, Z., Chen, Y., Song, J., Huang, Y., Song, K., Zhong, J., Xu, X., Wei, J., Wang, C., et al. (2020) · Theranostics · doi:10.7150/thno.44043 · Cited by 55
Menon, D. R., Hammerlindl, H., Torrano, J., Schaider, H., & Fujita, M. (2020) · Theranostics · doi:10.7150/thno.42523 · Cited by 57
Insight on Transcriptional Regulation of the Energy Sensing AMPK and Biosynthetic mTOR Pathway Genes
Sukumaran, A., Choi, K., & Dasgupta, B. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00671 · Cited by 62
A continuous, fluorogenic sirtuin 2 deacylase assay: substrate screening and inhibitor evaluation
Galleano, I., Schiedel, M., Jung, M., Madsen, A. S., & Olsen, C. A. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01532 · Cited by 53
Wan, X., & Garg, N. J. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.693051 · Cited by 55
Roles for the 8-Oxoguanine DNA Repair System in Protecting Telomeres From Oxidative Stress
Rosa, M. D., Johnson, S. A., & Opresko, P. L. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.758402 · Cited by 58
Lindholm, M. E., Fischer, H., Poellinger, L., Johnson, R. S., Gustafsson, T. P., Sundberg, C. J., & Rundqvist, H. (2014) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00036.2013 · Cited by 54
Birds and longevity: Does flight driven aerobicity provide an oxidative sink?
Hickey, A. J., Jüllig, M., Aitken, J. F., Loomes, K. M., Hauber, M. E., & Phillips, A. R. J. (2011) · Ageing Research Reviews · doi:10.1016/j.arr.2011.12.002 · Cited by 59
A fluorogenic assay for screening Sirt6 modulators
Hu, J., He, B., Bhargava, S., & Lin, H. (2013) · Organic & Biomolecular Chemistry · doi:10.1039/c3ob41138a · Cited by 53
Slowing Down Ageing: The Role of Nutrients and Microbiota in Modulation of the Epigenome
Gadecka, A., & Bielak-Żmijewska, A. (2019) · Nutrients · doi:10.3390/nu11061251 · Cited by 56
Raza, S. H. A., Khan, R., Abdelnour, S. A., El-Hack, M. E. A., Khafaga, A. F., Taha, A. E.-S., Ohran, H., Mei, C., Schreurs, N. M., & Zan, L. (2019) · Genes · doi:10.3390/genes10090717 · Cited by 57
Sirtuin 6 (SIRT6) regulates redox homeostasis and signaling events in human articular chondrocytes
Collins, J. A., Kapustina, M., Bolduc, J. A., Pike, J. F. W., Diekman, B. O., Mix, K. S., Chubinskaya, S., Eroğlu, E., Michel, T. M., Poole, L. B., et al. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.01.054 · Cited by 51
Inactivation of the Sas2 histone acetyltransferase delays senescence driven by telomere dysfunction
Kozak, M., Chavez, A., Dang, W., Berger, S. L., Ashok, A., Guo, X., & Johnson, F. B. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.314 · Cited by 52
Sirtuin‐6 deficiency exacerbates diabetes‐induced impairment of wound healing
Thandavarayan, R. A., Garikipati, V. N. S., Joladarashi, D., Babu, S. S., Jeyabal, P., Verma, S. K., Mackie, A. R., Khan, M., Arumugam, S., Watanabe, K., et al. (2015) · Experimental Dermatology · doi:10.1111/exd.12762 · Cited by 52
Targeting Sirtuins: Substrate Specificity and Inhibitor Design
Rajabi, N., Galleano, I., Madsen, A. S., & Olsen, C. A. (2018) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2017.11.003 · Cited by 52
Sirtuin-4 (SIRT4), a therapeutic target with oncogenic and tumor-suppressive activity in cancer
Huang, G., & Zhu, G. (2018) · OncoTargets and Therapy · doi:10.2147/ott.s157724 · Cited by 53
Cowell, W., Colicino, E., Tanner, E. M., Amarasiriwardena, C. J., Andra, S. S., Bollati, V., Kannan, S., Ganguri, H. B., Gennings, C., Wright, R. O., et al. (2020) · Environmental Research · doi:10.1016/j.envres.2020.110009 · Cited by 52
Lee, O.-H., Woo, Y. M., Moon, S., Lee, J., Park, H., Jang, H. S., Park, Y., Bae, S., Park, K., Heo, J. H., et al. (2020) · Aging · doi:10.18632/aging.202176 · Cited by 52
Epigenetic Regulation of Metabolism and Inflammation by Calorie Restriction
Hernández‐Saavedra, D., Moody, L., Xu, G. B., Chen, H., & Pan, Y. (2018) · Advances in Nutrition · doi:10.1093/advances/nmy129 · Cited by 52
The NAD + -Dependent Family of Sirtuins in Cerebral Ischemia and Preconditioning
Khoury, N., Koronowski, K. B., Young, J. I., & Pérez‐Pinzón, M. A. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7258 · Cited by 51
Qin, K., Zhang, N., Zhang, Z., NIPPER, M. J., Zhu, Z., Leighton, J., Xu, K., Musi, N., & Wang, P. (2018) · Diabetologia · doi:10.1007/s00125-017-4542-6 · Cited by 51
Mechanism of activation for the sirtuin 6 protein deacylase
Klein, M. A., Liu, C., Kuznetsov, V. I., Feltenberger, J. B., Tang, W., & Denu, J. M. (2020) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)49896-6 · Cited by 51
Maissan, P., Mooij, E., & Barberis, M. (2021) · Biology · doi:10.3390/biology10030194 · Cited by 52
The sirtuins: Markers of metabolic health
Covington, J. D., & Bajpeyi, S. (2015) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201500340 · Cited by 51
Hwang, B., Jin, J., Gao, Y. D., Shi, G., Madabushi, A., Yan, A., Guan, X., Zalzman, M., Nakajima, S., Lan, L., et al. (2015) · BMC Molecular Biology · doi:10.1186/s12867-015-0041-9 · Cited by 49
Telomere length, telomerase expression, and oxidative stress in lead smelters
Pawlas, N., Płachetka, A., Kozłowska, A., Mikołajczyk, A., Kasperczyk, A., Dobrakowski, M., & Kasperczyk, S. (2015) · Toxicology and Industrial Health · doi:10.1177/0748233715601758 · Cited by 50
Afzaal, A., Rehman, K., Kamal, S., & Akash, M. S. H. (2022) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.23047 · Cited by 49
Sirtuin 6 inhibits colon cancer progression by modulating PTEN/AKT signaling
Tian, J., & Yuan, L. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.06.070 · Cited by 48
Chen, X., Amorim, J. A., Moustafa, G. A., Lee, J., Yu, Z., Ishihara, K., Iesato, Y., Barbisan, P. R. T., Ueta, T., Togka, K. A., et al. (2020) · Aging · doi:10.18632/aging.202453 · Cited by 47
Ding, Y.-N., Wang, T., Lv, S., Tang, X., Wei, Z., Yao, F., Xu, H., Chen, Y.-N., Wang, X., Wang, H.-Y., et al. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01456-x · Cited by 48
TRF1 and TRF2 binding to telomeres is modulated by nucleosomal organization
Galati, A., Micheli, E., Alicata, C., Ingegnere, T., Cicconi, A., Pusch, M. C., Giraud-Panis, M.-J. E., Gilson, É., & Cacchione, S. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv507 · Cited by 47
Targeting sirtuins for the treatment of diabetes
Huynh, F. K., Hershberger, K. A., & Hirschey, M. D. (2013) · Diabetes Management · doi:10.2217/dmt.13.6 · Cited by 48
Sirtuins, Bioageing, and Cancer
McGuinness, D. H., McGuinness, D. H., McCaul, J. A., & Shiels, P. G. (2011) · Journal of Aging Research · doi:10.4061/2011/235754 · Cited by 48
Li, Y., Meng, X., Wang, W., Liu, F., Hao, Z.-R., Yang, Y., Zhao, J., Yin, W., Xu, L., Zhao, R., et al. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00394 · Cited by 47
Sabir, M. S., Khan, Z., Hu, C., Galligan, M. A., Dussik, C. M., Mallick, S., Stone, A. D., Batie, S. F., Jacobs, E. T., Whitfield, G. K., et al. (2017) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2017.06.010 · Cited by 45
Emerging roles of telomeric chromatin alterations in cancer
Cacchione, S., Biroccio, A., & Rizzo, A. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1030-5 · Cited by 47
Sirtuin 6: A potential therapeutic target for cardiovascular diseases
Xie, S., Deng, W., & Qizhu, T. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105214 · Cited by 47
Sirt6 regulates postnatal growth plate differentiation and proliferation via Ihh signaling
Piao, J., Tsuji, K., Ochi, H., Iwata, M., Koga, D., Okawa, A., Morita, S., Takeda, S., & Asou, Y. (2013) · Scientific Reports · doi:10.1038/srep03022 · Cited by 47
Regulation of Gene Expression through Food—Curcumin as a Sirtuin Activity Modulator
Ungurianu, A., Zanfirescu, A., & Margina, D. M. (2022) · Plants · doi:10.3390/plants11131741 · Cited by 50
Writers, Readers, and Erasers of Epigenetic Marks
Nicholson, T. B., Veland, N., & Chen, T. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800206-3.00003-3 · Cited by 49
Simeoni, F., Tasselli, L., Tanaka, S., Villanova, L., Hayashi, M., Kubota, K., Isono, F., Garcia, B. A., Michishita-Kioi, E., & Chua, K. F. (2013) · Scientific Reports · doi:10.1038/srep03085 · Cited by 47
Self-citationThe biological significance of histone modifiers in multiple myeloma: clinical applications
Ohguchi, H., Hideshima, T., & Anderson, K. C. (2018) · Blood Cancer Journal · doi:10.1038/s41408-018-0119-y · Cited by 47
Regulation and protection of mitochondrial physiology by sirtuins
Pereira, C. V., Lebiedzińska, M., Wieckowski, M. R., & Oliveira, P. J. (2011) · Mitochondrion · doi:10.1016/j.mito.2011.07.003 · Cited by 46
SIRT6 inhibitors with salicylate-like structure show immunosuppressive and chemosensitizing effects
Damonte, P., Sociali, G., Parenti, M. D., Soncini, D., Bauer, I., Boero, S., Grozio, A., von Holtey, M., Piacente, F., Becherini, P., et al. (2017) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2017.09.023 · Cited by 45
Claessens, A., Harris, L. M., Stanojčić, S., Chappell, L., Stanton, A., Kuk, N., Veneziano-Broccia, P., Sterkers, Y., Rayner, J., & Merrick, C. J. (2018) · PLoS Genetics · doi:10.1371/journal.pgen.1007490 · Cited by 39
Song, M., Ha, S. H., Ryoo, G.-H., Kim, M.-K., Cha, H.-N., Park, S., Hwang, H. P., Yu, H. C., Bae, E. J., & Park, B. (2019) · Experimental & Molecular Medicine · doi:10.1038/s12276-019-0256-9 · Cited by 47
Environmental pollutants exposure: A potential contributor for aging and age-related diseases
Liu, Y., Wang, J., Huang, Z., Liang, J., Xia, Q., Xia, Q., & Liu, X. (2020) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2020.103575 · Cited by 46
Zhang, Z., Ren, S., Tan, Y., Li, Z.-Z., Tang, X., Wang, T., Hao, D., Zhao, X., Chen, H., & Liu, D. (2016) · Scientific Reports · doi:10.1038/srep23912 · Cited by 44
Sirtuins and their interactions with transcription factors and poly(ADP-ribose) polymerases
Jęśko, H. M., & Strosznajder, R. P. (2016) · Folia Neuropathologica · doi:10.5114/fn.2016.62531 · Cited by 44
Roles of SIRT6 in kidney disease: a novel therapeutic target
Yang, X., Feng, J., Liang, W., Zhu, Z., Chen, Z., Hu, J., Yang, D., & Ding, G. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-04061-9 · Cited by 46
Sub-cellular localization, expression and functions of Sirt6 during the cell cycle in HeLa cells
Ardestani, P. M., & Liang, F. (2012) · Nucleus · doi:10.4161/nucl.21134 · Cited by 45
Telomeric nucleosomes: Forgotten players at chromosome ends
Pisano, S., Galati, A., & Cacchione, S. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8307-8 · Cited by 46
Cryo-EM structure of the human Sirtuin 6–nucleosome complex
Chio, U. S., Rechiche, O., Bryll, A. R., Zhu, J., Leith, E. M., Feldman, J. L., Peterson, C. L., Tan, S., & Armache, J. (2023) · Science Advances · doi:10.1126/sciadv.adf7586 · Cited by 39
Sirtuins: The NAD + -Dependent Multifaceted Modulators of Inflammation
Santos, L., Benítez-Rosendo, A., Bresque, M., Camacho-Pereira, J., Calliari, A. J., & Escande, C. (2023) · Antioxidants and Redox Signaling · doi:10.1089/ars.2023.0295 · Cited by 49
Emerging role of sirtuins on tumorigenesis: possible link between aging and cancer
Cha, Y. I., & Kim, H.-S. (2013) · BMB Reports · doi:10.5483/bmbrep.2013.46.9.180 · Cited by 43
Singh, N., Ravichandran, S., Norton, D. D., Fugmann, S. D., & Moaddel, R. (2013) · Analytical Biochemistry · doi:10.1016/j.ab.2013.01.018 · Cited by 43
Biological significance of protein modifications in aging and calorie restriction
Nakamura, A., Kawakami, K., Kametani, F., Nakamoto, H., & Goto, S. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05374.x · Cited by 46
Majocchi, S., Aritonovska, E., & Mermod, N. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt880 · Cited by 44
Characterization of physiological defects in adult SIRT6-/- mice
Peshti, V., Obolensky, A., Nahum, L., Kanfi, Y., RATHAUS, M., Avraham, M., Tinman, S., Alt, F. W., Banin, E., & Cohen, H. Y. (2017) · PLoS ONE · doi:10.1371/journal.pone.0176371 · Cited by 44
Sirtuin 6 plays an oncogenic role and induces cell autophagy in esophageal cancer cells
Huang, N. J., Liu, Z., Zhu, J., Cui, Z., Li, Y., Yu, Y., Sun, F., Pan, Q., & Yang, Q. (2017) · Tumor Biology · doi:10.1177/1010428317708532 · Cited by 43
Denu, R. A., & Hematti, P. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.02.042 · Cited by 43
Sirtuins and cognition: implications for learning and memory in neurological disorders
Fagerli, E. A., Escobar, I., Ferrier, F. J., Jackson, C. W., Lao, E. J. P., & Pérez‐Pinzón, M. A. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.908689 · Cited by 43
Bi, S., Jiang, X., Ji, Q., Wang, Z., Ren, J., Wang, S., Yu, Y., Wang, R., Liu, Z., Liu, J., et al. (2024) · Developmental Cell · doi:10.1016/j.devcel.2024.02.008 · Cited by 45
Karvinen, S. M., Silvennoinen, M., Vainio, P., Sistonen, L., Koch, L. G., Britton, S. L., & Kainulainen, H. (2016) · Experimental Gerontology · doi:10.1016/j.exger.2016.03.015 · Cited by 44
Metadata
- Authors
- Michishita, E., McCord, R. A., Berber, E., Kioi, M., Padilla-Nash, H., Damian, M., Cheung, P., Kusumoto, R., Kawahara, T. L. A., Barrett, J. C., Chang, H. Y., Bohr, V. A., Ried, T., Gozani, O., & Chua, K. F.
- Affiliations
- Stanford Medicine (US)
- VA Palo Alto Health Care System (US)
- Department of Biological Sciences (RU)
- National Institutes of Health (US)
- Corresponding author
- Chua, Katrin F.
- ORCID
- Venue
- Nature
- Published
- 2008-03
- Volume
- 452
- Issue
- 7186
- Pages
- 492-496
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC2646112
- OpenAlex
- W2029969982
- Semantic Scholar
- e93e298451cb0d965e8933da9a3ab04e44f65ff0
- Cited by
- 1,111
- References
- 32
- Citations by year
- 2026: 35 · 2025: 35 · 2024: 45 · 2023: 59 · 2022: 57 · 2021: 68 · 2020: 75 · 2019: 64 · 2018: 75 · 2017: 63 · 2016: 83 · 2015: 68 · 2014: 62 · 2013: 94 · 2012: 57
- FWCI
- 23.11
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Institute on Aging (R01AG028867, K08AG028961)
- National Institute of General Medical Sciences (R01GM079641)
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Structure and Function
- Keywords
- SIRT6, telomeric chromatin, telomere maintenance, premature aging, Werner syndrome, WRN, cellular senescence, chromatin silencing, telomere dysfunction, NAD+-dependent deacetylation
- MeSH terms
- Werner Syndrome Helicase, Acetylation, Cell Line, Chromatin, DNA Replication, Exodeoxyribonucleases, Fibroblasts, Histone Deacetylases, Histones, Humans, Lysine, Phenotype, Protein Binding, Werner Syndrome, Telomere, Cellular Senescence, Telomerase, Sirtuins, RecQ Helicases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-06, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-06 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
